Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.

Ultra Liver is a highly active support supplement in the facilitation of liver health, liver function, and detoxification.

Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very ...

Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...

Announcing a new publication for Acta Materia Medica journal. Excessive consumption of acetaminophen (APAP) has emerged as ...

At least 124 people have died in Ankara and Istanbul in the past six weeks after drinking bootleg alcohol, and dozens more are in intensive care, state news agency Anadolu said Monday.Some 54 people ...

Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...

Inquest opens into death of Barton on Sea man discovered unresponsive in bed (Image: Newsquest.) AN INQUEST has opened into the death of a Barton on Sea man who was found unresponsive in his bed.

TSCA/FIFRA/TRI - EPA Releases Final Risk Evaluation For DINP, Finding Unreasonable Risk Of Injury To Human Health When Workers ...

Life Extension shares 21 science-backed tips to help you establish a wellness-focused lifestyle and keep you in top-notch ...